Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study
- DOI
- 10.1016/j.lungcan.2025.108548
- Published
- 2025-05
- Container
- Lung Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2025.108548,
title = {Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study},
author = {Christos Chouaid and Lise Bosquet and Craig Knott and Ziming Li and Marcy Schaeffer and Xiwu Lin and Claudio A. Schioppa and Nolen Joy Perualila and Joris Diels and Eduardo Quintero Caparros and Francesca Galea and Annika Hultén and Alastair Greystoke},
year = {2025},
journal = {Lung Cancer},
doi = {10.1016/j.lungcan.2025.108548},
url = {https://doi.org/10.1016/j.lungcan.2025.108548}
}RIS
TY - JOUR TI - Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study AU - Christos Chouaid AU - Lise Bosquet AU - Craig Knott AU - Ziming Li AU - Marcy Schaeffer AU - Xiwu Lin AU - Claudio A. Schioppa AU - Nolen Joy Perualila AU - Joris Diels AU - Eduardo Quintero Caparros AU - Francesca Galea AU - Annika Hultén AU - Alastair Greystoke PY - 2025 JO - Lung Cancer DO - 10.1016/j.lungcan.2025.108548 UR - https://doi.org/10.1016/j.lungcan.2025.108548 ER -
APA
Chouaid, C., Bosquet, L., Knott, C., Li, Z., Schaeffer, M., Lin, X., Schioppa, C. A., Perualila, N. J., Diels, J., Caparros, E. Q., Galea, F., Hultén, A., & Greystoke, A. (2025). Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study. Lung Cancer. https://doi.org/10.1016/j.lungcan.2025.108548
Source records
- crossref · retrieved 2026-09-25T20:58:06.291Z